# ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
> **ANDA217830** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMACEUTICALS LTD · Approved 2025-09-17
## Drug
- **FDA Application Number:** ANDA217830
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
- **Generic name:** Abacavir, Dolutegravir, Lamivudine
- **Active ingredients:** ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MACLEODS PHARMACEUTICALS LTD
- **First approval:** 2025-09-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217830)
---
*AI Analytics · CC0 1.0*